400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / 5-HT Receptor / Intepirdine
CAS No.: 607742-69-8
Synonyms: SB-742457;GSK-742457;RVT-101
SB-742457 is a selective 5-HT6 receptor antagonist with Ki value of 1.4 nM, showing potential cognition, memory, and learning-enhancing effects.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02669433 | Dementia With Lewy Bodies | Phase 2 | Completed | - | - |
NCT02910102 | Alzheimer's Disease ... more >> Dementia With Lewy Bodies Parkinson's Disease Dementia Collapse << | Phase 2 | Completed | - | United States, Arizona ... more >> US101 Phoenix, Arizona, United States, 85013 United States, California US118 Simi Valley, California, United States, 93065 US117 Temecula, California, United States, 92591 United States, Florida US115 Boca Raton, Florida, United States, 33431 US109 Hallandale Beach, Florida, United States, 33009 US116 Miami, Florida, United States, 33137 US108 Pensacola, Florida, United States, 32502 United States, Georgia US106 Columbus, Georgia, United States, 31909 United States, Indiana US107 Indianapolis, Indiana, United States, 46202 United States, Michigan US102 Ann Arbor, Michigan, United States, 48106 United States, Ohio US111 Columbus, Ohio, United States, 43210 Collapse << |
NCT02586909 | Alzheimer's Disease | Phase 3 | Terminated(Intepirdine did not... more >> meet its primary efficacy endpoints in lead-in study RVT-101-3001.) Collapse << | - | - |
实验方案
技术信息
CAS号 | 607742-69-8 | 储存条件 |
|
|||||||||
分子式 | C19H19N3O2S | 运输 | 蓝冰 | |||||||||
分子量 | 353.44 | 别名 | SB-742457;GSK-742457;RVT-101;RVT101. intepirdine | |||||||||
溶解度 |
|
动物实验配方 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02669433 | Dementia With Lewy Bodies | Phase 2 | Completed | - | - |
NCT02910102 | Alzheimer's Disease ... more >> Dementia With Lewy Bodies Parkinson's Disease Dementia Collapse << | Phase 2 | Completed | - | United States, Arizona ... more >> US101 Phoenix, Arizona, United States, 85013 United States, California US118 Simi Valley, California, United States, 93065 US117 Temecula, California, United States, 92591 United States, Florida US115 Boca Raton, Florida, United States, 33431 US109 Hallandale Beach, Florida, United States, 33009 US116 Miami, Florida, United States, 33137 US108 Pensacola, Florida, United States, 32502 United States, Georgia US106 Columbus, Georgia, United States, 31909 United States, Indiana US107 Indianapolis, Indiana, United States, 46202 United States, Michigan US102 Ann Arbor, Michigan, United States, 48106 United States, Ohio US111 Columbus, Ohio, United States, 43210 Collapse << |
NCT02586909 | Alzheimer's Disease | Phase 3 | Terminated(Intepirdine did not... more >> meet its primary efficacy endpoints in lead-in study RVT-101-3001.) Collapse << | - | - |
NCT02928445 | Dementia With Lewy Bodies | Phase 2 Phase 3 | Terminated(Intepirdine did not... more >> meet its primary efficacy endpoints in the lead-in study RVT-101-2001.) Collapse << | - | - |
NCT02585934 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT00348192 | Alzheimer's Disease | Phase 2 | Completed | - | Austria ... more >> GSK Investigational Site Hall in Tirol, Austria, A-6060 GSK Investigational Site Vienna, Austria, A-1130 GSK Investigational Site Vienna, Austria, A-1220 Bulgaria GSK Investigational Site Sofia, Bulgaria, 1113 GSK Investigational Site Sofia, Bulgaria, 1431 GSK Investigational Site Varna, Bulgaria, 9010 Chile GSK Investigational Site Providencia / Santiago, Región Metro De Santiago, Chile, 7500710 GSK Investigational Site Santiago, Región Metro De Santiago, Chile, 7560356 GSK Investigational Site Valparaiso, Valparaíso, Chile, 2352499 Estonia GSK Investigational Site Tallinn, Estonia, 10617 GSK Investigational Site Tartu, Estonia, 51014 Germany GSK Investigational Site Ostfildern, Baden-Wuerttemberg, Germany, 73760 GSK Investigational Site Huettenberg, Hessen, Germany, 35625 GSK Investigational Site Achim, Niedersachsen, Germany, 28832 GSK Investigational Site Baesweiler, Nordrhein-Westfalen, Germany, 52499 GSK Investigational Site Hattingen, Nordrhein-Westfalen, Germany, 45525 Russian Federation GSK Investigational Site Moscow, Russian Federation, 115552 GSK Investigational Site Moscow, Russian Federation, 117049 GSK Investigational Site St. Petersburg, Russian Federation, 197022 GSK Investigational Site St.-Petersburg, Russian Federation, 198103 Slovakia GSK Investigational Site Bratislava, Slovakia, 811 01 GSK Investigational Site Bratislava, Slovakia, 826 06 GSK Investigational Site Bratislava, Slovakia, 831 03 United Kingdom GSK Investigational Site Bradford, United Kingdom, BD7 1HR GSK Investigational Site Swindon, United Kingdom, SN1 4HZ GSK Investigational Site West of Scotland Science Park, Glasgow, United Kingdom, G20 0XA Collapse << |
NCT02585934 | - | - | Completed | - | - |
NCT00224497 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT00708552 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT00551772 | Alzheimer's Disease | Phase 1 | Completed | - | United States, Indiana ... more >> GSK Investigational Site Evansville, Indiana, United States, 47714 Collapse << |
NCT00708552 | - | - | Completed | - | - |
NCT00710684 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT00710684 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网